Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06235190 · ClinicalTrials.gov registry record · NA

Assessment of the Safety and Efficacy of the Felix NeuroAI Wristband in Essential Tremor

A NA study of Essential Tremor, sponsored by Fasikl.

Active
Registry status
NA
Development phase
126
Enrollment target
12
Study locations

NCT06235190 is a NA study of Essential Tremor that is active but no longer recruiting, run by Fasikl. The registered enrollment target is 126 participants, below the 400-participant average among 41 other Essential Tremor trials with a reported enrollment target (68% lower). The trial reports 12 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06235190, a NA study of Essential Tremor, is active but no longer recruiting, sponsored by Fasikl.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
126 participants
Enrollment target
12
Study locations

Study Summary

The goal of this clinical study is to compare Felix NeuroAI Wristband and sham device in patients with essential tremor. The main question it aims to answer is: • Is Felix a safe and efficacious treatment for patients with essential tremor? Participants will be treated with either Felix or Sham for a period of up to 90 days. After that, they will be eligible to participate in a long-term, open-label study and be treated with Felix.

Conditions Studied

Essential Tremor

Interventions

  • DEVICE Sham Device
  • DEVICE Felix NeuroAI Wristband

Study Locations (12)

New York

  • Parkinson's Research Centers of America - Long Island - Commack
  • Columbia University Irving Medical Center - New York

Zhejiang

  • The First Affiliated Hospital, Zhejiang University School of Medicine - Hangzhou
  • Sir Run Run Shaw Hospital - Hangzhou

Other

  • Xuanwu Hospital Capital Medical University - Beijing
  • Tianjin Medical University General Hospital - Tianjin

Arizona

  • Barrow Neurological Institute - Phoenix

California

  • Parkinson's Research Centers of America - Palo Alto - Palo Alto

Florida

  • Parkinson's Disease and Movement Disorders Center of Boca Raton - Boca Raton

Kansas

  • The University Of Kansas Medical Center - Kansas City

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2024-02-27
Est. Completion 2025-11
Phase NA

Sponsor

Fasikl

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06235190

The ClinicalTrials.gov registry entry for NCT06235190 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 400-participant average among 41 other Essential Tremor trials with a reported enrollment target (68% lower). The listed sponsor is Fasikl, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Essential Tremor appearing as the primary indexed condition, and to 2 interventions - of which Sham Device is the first listed.

NCT06235190 reports 12 study locations spanning 9 distinct geographic areas - top geographies include New York, Zhejiang, Other.

Frequently Asked Questions

What is clinical trial NCT06235190 about?

NCT06235190 is a clinical study titled "Assessment of the Safety and Efficacy of the Felix NeuroAI Wristband in Essential Tremor". The goal of this clinical study is to compare Felix NeuroAI Wristband and sham device in patients with essential tremor. The main question it aims to answer is: • Is Felix a safe and efficacious treatment for patients with essential tremor? Participants will be treated with either Felix or Sham fo...

What is the current status of trial NCT06235190?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2024-02-27. Estimated completion is 2025-11.

What conditions does trial NCT06235190 study?

This clinical trial studies the following conditions: Essential Tremor.

What interventions are being tested in trial NCT06235190?

The interventions under investigation include: Sham Device (DEVICE), Felix NeuroAI Wristband (DEVICE).

Who is sponsoring clinical trial NCT06235190?

This trial is sponsored by Fasikl, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06235190 being conducted?

This trial has 12 study locations across Arizona, California, Florida, Kansas, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Essential Tremor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Essential Tremor

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.